Name

Dr. Stuart Hodgetts - Publications
2006	Hodgetts S, Radley H, Davies M, Grounds MD. (2006) "Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFa function with Etanercept in mdx mice." Neuromuscular Disorders 16 pp591-602.
2005	Grounds MD, Davies M, Torrisi J, Shavlakadze J, Hodgetts S. (2005) "Silencing TNFa activity using Remicade® or Enbrel® blocks inflammation in whole muscle grafts: an in vivo bioassay to assess the efficacy of anti-cytokine drugs in mice." Cell and Tissue Research. 320(3):509-15
2004	Bosio E., Pullen T,F., Fragall C.T., Beilharz M.W., Bennett A.L., Grounds M.D., Hodgetts S.I. and Sammels L. (2004) "A comparison between real-time quantitative PCR and DNA hybridisation for quantitation of male DNA following myoblast transplantation." Cell Transplantation, 13(7-8), pp. 817-821.
2003	Hodgetts S.I. and Grounds MD (2003). "Irradiation of dystrophic host tissue prior to Myoblast Transfer Therapy enhances initial (but not long-term) survival of donor myoblasts." J. Cell Science Oct 15;116(Pt 20):4131-4146.
	Hodgetts S.I., Spencer M. and Grounds M.D. (2003) "A Role for Natural Killer Cells in the Rapid Death of Cultured Donor Myoblasts After Transplantation". Transplantation 75: p863-871
	Hodgetts S.I. and Grounds M.D. (2003). "Irradiation of dystrophic host tissue prior to Myoblast Transfer Therapy enhances initial (but not long-term) survival of donor myoblasts." Journal of Cell Science 116: p4131-4146.
pdf	Hodgetts S.I., Spencer M. and Grounds M.D. (2003) "A Role for Natural Killer Cells in the Rapid Death of Cultured Donor Myoblasts After Transplantation " Transplantation 75: p863-871
2002	Sammels L.C., Fragall C., Hodgetts S.I., Grounds M.D. and Beilharz M. (2002). "Myoblast transfer therapy (MTT): CFSE Labelling of Donor Myoblasts to Track Their Fate in Recipient Mdx Mice". J. Neurological Sciences 199, Supplement 1 P-043
2001	Stuart I. Hodgetts and Miranda D. Grounds. (2001). "Natural Killer Cells and the Death of Donor Myoblasts in Myoblast Transfer Therapy." Cell Transplantation 10 (6) p512.
	Smythe GM, Hodgetts S.I., Grounds M.D. (2001). INVITED REVIEW: "Problems and Solutions in Myoblast Transfer Therapy". Journal of Cellular and Molecular Medicine 5(1): 33-47.
	Stuart I Hodgetts and Miranda D. Grounds. (2001) "Complement and myoblast transfer therapy: Donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5". Immunology and Cell Biology 79 (3): 231-239.
2000	Smythe G.M., Hodgetts S.I. and Grounds M.D. (2000). "Immunobiology and the Future of Myoblast Transfer Therapy". Molecular Therapy. 1(4): 304 -313. [see http:www.apnet.com/moltherapy].
	Hodgetts S.I., Beilharz M.W., Scalzo A.A. and Grounds M.D. (2000). "Why Do Cultured Transplanted Myoblasts Die In Vitro? DNA Quantification Shows Enhanced Survival of Donor Male Myoblasts in Host Mice Depleted of CD4+ and CD8+ or NK1.1+ Cells." Cell Transplantation 9(4): 489-502.
1999	Hodgetts S.I. and Grounds M.D. (1999). "Isolation of Mouse Skeletal Muscle Myoblasts with Blendzyme 3". Roche Molecular Biochemicals Website: http://www.collagenase.com/prodinfo_fst.htm?/
	Urosevic N., Silvia O., Sangster M.Y., Mansfield J.P., Hodgetts S.I. and Shellam G.R. (1999). "Development and Characterisation of New Flavivirus-resistant Mouse Strains Bearing Flvr-like and Flvmr Alleles from Wild or Wild-derived Animals." Journal of General Virology 80: 897-906.
1998	Hodgetts S.I., Davies M., Smythe G.M., Fan Y., Beilharz M.W. and Grounds M.D. (1998). "Quantitation of Donor Male Myoblast Survival in Cell Transplantation Experiments in Dystrophic Mice." Muscle and Nerve Supplement 7 pS126.
1997	Lancaster M.U., Hodgetts S.I., Mackenzie J.S. and Urosevic N. (1997). "Characterisation of Viral Defective RNA Produced During Persistent Infection of Vero Cells with Murray Valley Encephalitis Virus." Journal of General Virology 72(3): 2474-82.
1995	Hodgetts S.I., Buchanan K.L., Byrnes J. and Webb C.F. (1995). "Differential Interaction of Nuclear Matrix Proteins with Regulatory Sequences Upstream of Immunoglobulin Heavy Chain Promoters." Journal of Cellular Biochemistry Supplement 19D.
	Buchanan K.L., Hodgetts S.I., Byrnes J. and Webb C.F. (1995). "Differential Transcription Efficiency of Two Ig VH Promoters In Vitro." Journal of Immunology 155: 4270-4277.